Evidence map›Paper›PMID 25404538›Full record

ArticleScientific reports2014

Combination of mild hypothermia with neuroprotectants has greater neuroprotective effects during oxygen-glucose deprivation and reoxygenation-mediated neuronal injury.

Xiao-Ya Gao, Jian-Ou Huang, Ya-Fang Hu, Yong Gu, Shu-Zhen Zhu, Kai-Bin Huang, Jin-Yu Chen, Su-Yue Pan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neuroprotection by Therapeutic Hypothermia.Frontiers in neuroscience · 2019
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Cortical Thickness of Native Tibetans in the Qinghai-Tibetan Plateau.AJNR. American journal of neuroradiology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xiao-Ya Gao1] Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China [2] Department of Neurology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Jian-Ou Huang1] Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China [2] Department of Neurology, the 421 Hospital, Guangzhou, Guangdong, P. R. China.
Ya-Fang HuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Yong GuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Shu-Zhen ZhuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Kai-Bin HuangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Jin-Yu ChenDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Su-Yue PanDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P. R. China.
Southern Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Co-treatment of neuroprotective reagents may improve the therapeutic efficacy of hypothermia in protecting neurons during ischemic stroke. This study aimed to find promising drugs that enhance the neuroprotective effect of mild hypothermia (MH). 26 candidate drugs were selected based on different targets. Primary cultured cortical neurons were exposed to oxygen-glucose deprivation and reoxygenation (OGD/R) to induce neuronal damage, followed by either single treatment (a drug or MH) or a combination of a drug and MH. Results showed that, compared with single treatment, combination of MH with brain derived neurotrophic factor, glibenclamide, dizocilpine, human urinary kallidinogenase or neuroglobin displayed higher proportion of neuronal cell viability. The latter three drugs also caused less apoptosis rate in combined treatment. Furthermore, co-treatment of those three drugs and MH decreased the level of reactive oxygen species (ROS) and intracellular calcium accumulation, as well as stabilized mitochondrial membrane potential (MMP), indicating the combined neuroprotective effects are probably via inhibiting mitochondrial apoptosis pathway. Taken together, the study suggests that combined treatment with hypothermia and certain neuroprotective reagents provide a better protection against OGD/R-induced neuronal injury.

Indexed as

AnimalsAnimals, NewbornApoptosisCalciumCell SurvivalCerebral CortexCold TemperatureCombined Modality TherapyCulture MediaDizocilpine MaleateGlobinsGlucoseKallikreinsMembrane Potential, MitochondrialMitochondriaNerve Tissue ProteinsCalciumCulture MediaDizocilpine MaleateGlobinsGlucoseKallikreinsNerve Tissue ProteinsNeuroglobinNeuroprotective AgentsOxygenReactive Oxygen Species

Identifiers

PMID25404538
PMCPMC4665348
OpenAlexW1993241503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.